Implementing a Home Blood Pressure Monitoring Program in Primary Care

NCT ID: NCT05885997

Last Updated: 2025-04-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

23928 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-11-01

Study Completion Date

2026-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this research is to determine whether a theory-informed implementation strategy is successful at increasing the uptake of a supported home blood pressure monitoring (HBPM) program as well as to determine the effectiveness of this evidence-based practice when implemented across multiple practices serving a diverse patient population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hypertension guidelines now strongly recommend that patients with hypertension monitor their blood pressure (BP) at home (i.e., home BP monitoring; HBPM) as an approach to improving BP control so long as HBPM is conducted with clinical support (i.e., supported HBPM). Yet, few health systems have systematically implemented HBPM programs, and less than 20% of hypertensive patients routinely measure their BP at home, resulting in a gap in the translation of evidence-based recommendations into practice.

While there is strong evidence for Supported HBPM from pragmatic randomized controlled trials (RCTs), the evidence has been generated from the subgroup of patients and clinicians who volunteered to participate in trials, and the sample sizes have been in the hundreds of patients. There remains a gap in assessing the effectiveness of a scaled-up HBPM program that seeks to maximize the enrollment of primary care patients with uncontrolled hypertension.

Accordingly, in partnership with health system leaders at New York-Presbyterian Hospital (NYP), Columbia University Irving Medical Center, and Weill Cornell Medicine, the study investigator leveraged a system-wide investment in telemedicine to develop a telemonitoring-enabled Supported HBPM program. The Supported HBPM program consists of two options for obtaining electronic health record (EHR)-integrated home BP data. The low resource intensity option is designed for patients that can obtain valid home BP devices and are comfortable using the patient portal. It includes digital support to prompt patients to track their home BP readings in the patient portal using their own BP devices with automated triage support for extreme readings. The high resource intensity option is designed for patients that need additional support with HBPM. It involves navigator support with obtaining and using loaned home BP devices that wirelessly transmit data into the EHR and nursing support to triage extreme readings. Both programs can be ordered by clinicians in the EHR and both provide clinicians with weekly summaries of home BP readings with average home BP already calculated.

The study investigator concurrently followed a theory-driven process (the Behavior Change Wheel) to develop an implementation strategy aimed at increasing uptake of the Supported HBPM program. The study investigator now plans to implement and evaluate the Supported HBPM program across practices in the NYP, Weill Cornell Medicine, and ColumbiaDoctors primary care network which is comprised of a socioeconomically diverse patient population.

The study will evaluate the program by conducting a parallel-group cluster randomized trial in which 15 practices will be matched and then randomly assigned to early implementation of the Supported HBPM program (intervention) versus usual care with delayed implementation (i.e., wait-list control). Data will be retrospectively collected from a 12 month period before implementation (pre-implementation periods) as well as from a 12 month period after implementation (post-implementation period) to assess outcomes.

If successful, this project will provide a roadmap for widely implementing an EHR-integrated Supported HBPM program, and will accelerate a change in the paradigm of hypertension management from the office to the home.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Outcome Assessors
Data analysts will be blinded to group assignment when analyzing electronic health record data to determine the effectiveness of the program.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Clinics, Pre-Implementation Period

Usual care

Group Type EXPERIMENTAL

Usual care

Intervention Type OTHER

Usual care

Intervention Clinics, Post-Implementation Period

Access to Supported HBPM program plus a multifaceted implementation strategy designed to increase uptake of the program by primary care patients with uncontrolled hypertension

Group Type EXPERIMENTAL

Supported HBPM program plus multifaceted implementation strategy

Intervention Type BEHAVIORAL

Supported HBPM Program:

* Patients are loaned a wireless home BP device or use their own device
* Navigator or app support for onboarding and engaging patients in HBPM
* Nursing or app support for monitoring and triaging home BP data for extreme readings
* EHR integration of order for program and home BP data, with weekly feedback of home BP results to clinicians within the EHR

Multifaceted implementation strategy:

* Clinician education about the benefits of the program as well as training in how to refer and manage patients who are enrolled
* Prompts and reminders to increase clinician referrals
* Instructional materials for patients and clinicians
* Problem-solving meetings to tailor implementation for individual practices

Control Clinics, Pre-Implementation Period

Usual care

Group Type OTHER

Usual care

Intervention Type OTHER

Usual care

Control Clinics, Post-Implementation Period

Usual care

Group Type OTHER

Usual care

Intervention Type OTHER

Usual care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Usual care

Usual care

Intervention Type OTHER

Supported HBPM program plus multifaceted implementation strategy

Supported HBPM Program:

* Patients are loaned a wireless home BP device or use their own device
* Navigator or app support for onboarding and engaging patients in HBPM
* Nursing or app support for monitoring and triaging home BP data for extreme readings
* EHR integration of order for program and home BP data, with weekly feedback of home BP results to clinicians within the EHR

Multifaceted implementation strategy:

* Clinician education about the benefits of the program as well as training in how to refer and manage patients who are enrolled
* Prompts and reminders to increase clinician referrals
* Instructional materials for patients and clinicians
* Problem-solving meetings to tailor implementation for individual practices

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hypertension (as per International Statistical Classification of Diseases and Related Health Problems (ICD)-10 codes)
* At least one completed primary care office visit during relevant 6-month pre implementation or post-implementation study time period
* Age 18-85 years old


* Primary care practice that provides care to adult patients affiliated with New York Presbyterian's Ambulatory Care Network, ColumbiaDoctors, or Weill Cornell Medicine, including practices that specialize in HIV medicine

Exclusion Criteria

* Advanced dementia or other measure of frailty (as per ICD-10 codes)
* Pregnancy during measurement period (as per ICD-10 codes)
* Stage 5 or end-stage kidney disease (as per ICD-10 codes)
* Terminal illness/in hospice care (as per ICD-10 codes)

Practice-level


* Medical director declines participation in the trial
* Site for pilot testing the supported HBPM program or its implementation strategy
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Weill Medical College of Cornell University

OTHER

Sponsor Role collaborator

New York Presbyterian Hospital

OTHER

Sponsor Role collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

Sponsor Role collaborator

Columbia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ian Kronish

Associate Professor of Medicine at CUIMC, Associate Director of the Center for Behavioral Cardiovascular Health

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ian Kronish, MD

Role: PRINCIPAL_INVESTIGATOR

Columbia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Columbia University Irving Medical Center

New York, New York, United States

Site Status

Weill Medical College of Cornell University

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01HL152699

Identifier Type: NIH

Identifier Source: secondary_id

View Link

AAAS5544

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Team-Based Home Blood Pressure Monitoring
NCT05488795 ACTIVE_NOT_RECRUITING NA
Monitoring Blood Pressure at Home
NCT06247111 ACTIVE_NOT_RECRUITING NA
Mobile Health Management of Hypertension
NCT05856955 NOT_YET_RECRUITING NA
Conquering Hypertension in Urban Vietnam
NCT06893198 ENROLLING_BY_INVITATION NA